MMP14 and Alzheimer disease: It is now time to develop in vivo experimental models where genetic (i.e., conditional MT1-MMP knockout mice in transgenic AD mouse) and/or pharmacological (i.e., neutralizing antibodies) manipulation of MT1-MMP activity should further confirm the pathophysiological relevance of the aforementioned in vitro data.